Keyphrases
Epithelial Cancer Cells
50%
Cell-derived
50%
Breast Cancer
50%
CCL5
50%
Gene Expression
33%
Immune Cells
33%
Single-cell RNA Sequencing (scRNA-seq)
33%
Tumor
33%
Recurrence-free Survival
33%
Immune-competent
33%
Mutation Load
33%
Cell Line-derived Xenograft
33%
Neoantigen Load
33%
Tumor Immune Environment
33%
Higher Groups
33%
No Significant Difference
33%
Checkpoint Inhibition Therapy
33%
Differentially Expressed Genes
33%
In Vitro Cell Line
33%
RNA-seq Data
33%
Response to Immunotherapy
33%
Mouse Mammary Tumor
33%
Bulk RNA-seq
33%
Immune-compromised
33%
Balb C Mice
16%
Immunological Characteristics
16%
Tumor Protein p53 (TP53)
16%
Mouse Model
16%
Gene Signature
16%
Expression Data
16%
Immune-related
16%
Flow Cytometry
16%
Antitumor Effect
16%
Impact-based
16%
Human Tumors
16%
T Cells
16%
Mentorship
16%
Disciplinary Training
16%
Proof of Concept Study
16%
Patient Survival
16%
Clinical Significance
16%
Chemoattractant
16%
Immune Landscape
16%
Immunology
16%
Specific Marker
16%
High Fold
16%
Therapeutic Response
16%
Type-specific
16%
Therapeutic Strategies
16%
Syngeneic
16%
Specific Genes
16%
In Cancer
16%
Patient-derived Xenograft
16%
Mouse Tumor
16%
Immune System
16%
Expressed Genes
16%
Cancer Biology
16%
Epithelial Tumor Cells
16%
Breast Tumor
16%
Differential Expression
16%
Patient Response
16%
Bioinformatics
16%
Immune Parameters
16%
Epithelial Cells
16%
Somatic mutation
16%
Immunology and Microbiology
Mouse
100%
Cancer Cell
100%
Immunocompetent Cell
100%
Chemokine
100%
Gene Expression
66%
Neoantigen
33%
Tumor Cell
33%
Recurrence Free Survival
33%
Immune Landscape
33%
Syngenic
33%
Bagg Albino Mouse
33%
Immunology
33%
Chemoattractant
33%
Immunotherapy
33%
Cell Line
33%
Somatic Mutation
33%
Volume
33%
T Cell
33%
Immune System
33%
Mouse Model
33%
Xenograft
33%